Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Camrelizumab Combined with Chemotherapy and Local
Treatment in non-small cell lung cancer with brain metastases.